(Q38482584)

English

The effects of transdermal estradiol alone or with cyclical dydrogesterone on markers of cardiovascular disease risk in postmenopausal women with type 2 diabetes: a pilot study

scientific article published on July 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 September 2017

The effects of transdermal estradiol alone or with cyclical dydrogesterone on markers of cardiovascular disease risk in postmenopausal women with type 2 diabetes: a pilot study (English)

1 reference

Europe PubMed Central

3 September 2017

type 2 diabetes

1 reference

based on heuristic

inferred from title

cardiovascular disease in women

0 references

1 reference

based on heuristic

inferred from title

author name string

N D Stojanovic

1

1 reference

Europe PubMed Central

3 September 2017

P Kwong

2

1 reference

Europe PubMed Central

3 September 2017

D J Byrne

3

1 reference

Europe PubMed Central

3 September 2017

A Arnold

4

1 reference

Europe PubMed Central

3 September 2017

I A Jagroop

5

1 reference

Europe PubMed Central

3 September 2017

D Nair

6

1 reference

Europe PubMed Central

3 September 2017

M Press

7

1 reference

Europe PubMed Central

3 September 2017

S Hurel

8

1 reference

Europe PubMed Central

3 September 2017

D P Mikhailidis

9

1 reference

Europe PubMed Central

3 September 2017

G M Prelevic

10

1 reference

Europe PubMed Central

3 September 2017

publication date

1 July 2003

1 reference

Europe PubMed Central

3 September 2017

1 reference

Europe PubMed Central

3 September 2017

54

1 reference

Europe PubMed Central

3 September 2017

4

1 reference

Europe PubMed Central

3 September 2017

391-399

1 reference

Europe PubMed Central

3 September 2017

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400402

21 January 2018

In-hospital and 1-year mortality in 1,524 women after myocardial infarction. Comparison with 4,315 men.

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400402

21 January 2018

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400402

21 January 2018

Treating dyslipidaemia in non-insulin-dependent diabetes mellitus -- a special reference to statins

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400402

21 January 2018

Carotid atherosclerosis in type 2 diabetes mellitus: potential role of endothelin-1, lipoperoxides, and prostacyclin

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400402

21 January 2018

Insulin and atheroma. 20-yr perspective

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400402

21 January 2018

Hyperinsulinemia. A link between hypertension obesity and glucose intolerance

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400402

21 January 2018

Estrogen and coronary heart disease in women

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400402

21 January 2018

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400402

21 January 2018

Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400402

21 January 2018

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400402

21 January 2018

The effects of transdermal estradiol in combination with oral norethisterone on lipoproteins, coagulation, and endothelial markers in postmenopausal women with type 2 diabetes: a randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400402

21 January 2018

Hormone replacement therapy and cardiovascular risk in post-menopausal women with NIDDM.

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400402

21 January 2018

Lower diabetes risk with hormone replacement therapy: an encore for estrogen?

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400402

21 January 2018

Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400402

21 January 2018

A cross-sectional study of the effects of hormon replacement therapy on the cardiovascular disease risk profile in healthy postmenopausal women

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400402

21 January 2018

Advice on statistical analysis for Circulation Research

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400402

21 January 2018

Effects of postmenopausal hormone replacement therapy on central abdominal fat, glycemic control, lipid metabolism, and vascular factors in type 2 diabetes: a prospective study.

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400402

21 January 2018

The effects of improved glycemic control on complications in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400402

21 January 2018

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400402

21 January 2018

Clustering of cardiovascular risk factors in type 2 diabetes mellitus: prognostic significance and tracking

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400402

21 January 2018

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400402

21 January 2018

Different effects of oral conjugated equine estrogen and transdermal estrogen replacement therapy on size and oxidative susceptibility of low-density lipoprotein particles in postmenopausal women

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400402

21 January 2018

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400402

21 January 2018

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400402

21 January 2018

Elevated C-reactive protein values and atherosclerosis in sudden coronary death: association with different pathologies

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400402

21 January 2018

Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400402

21 January 2018

Identifiers

10.1177/000331970305400402

1 reference

Europe PubMed Central

3 September 2017

1 reference

Europe PubMed Central

3 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38482584&oldid=2118652699"